KIRTI PAL KAUR,RAJ KUMAR NARANG,KIRTI PAL KAUR,RAJ KUMAR NARANG
申请号：
IN2017/DEL/2015
公开号：
IN2015DE02017A
申请日:
2015.07.03
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
This present invention has achieved the high concentration of anti tubercular drugs (ATDs) in the selectively cellular tropics of infection compared to blood plasma pool region by formulating novel ligand appended liposomal delivery systems with increased bioavailability and site specificity. Furthermore, drug resistance can be averted effectively by multi drug combination, therefore this mode of therapy prove to be of great therapeutic potential ensuring complete eradiation of cellular pathogens. Additionally, this will reduce down the period of treatment frequency of dosage regimen as a consequence would be cost effective.
